Arrhythmia Research Technology (HRT) Q2 Loss Widens to $1.06/Share
Tweet Send to a Friend
Arrhythmia Research Technology (NYSE: HRT) reported Q2 EPS of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
